HDAC9 and malignant colon neoplasm: Okonkwo et al. [147] investigated SFN and its structural analogs as modifiers of HDAC and histone acetyltransferase activity (HAT), as well as anticancer effects on human colon cancer cell lines HCT-116 and SW480.